Shulman, L.P.
Mayo Clinic
Fox Chase Cancer Ctr, Philadelphia, PA; Dana-Farber Cancer Inst, Boston, MA; Montefiore Medcl Ctr, Bronx, NY; Mayo Clinic, Jacksonville, FL; John Wayne Cancer Institute, Santa Monica, CA; Sidney Kimmel Cancer Ctr at Johns Hopkins, Baltimore, MD
Citations 1
E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer
Goldstein, Lori J. , O’Neill, Anne, Sparano, JA, Perez, EA, Shulman, L.P., Martino, Silvana, Davidson, N.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 512-512
